Membrane oxygenator longevity was higher in argatroban‐treated patients undergoing vvECMO
Sign Up to like & getrecommendations! Published in 2023 at "European Journal of Clinical Investigation"
DOI: 10.1111/eci.13963
Abstract: In severe acute respiratory distress syndrome (ARDS), venovenous extracorporeal membrane oxygenation (vvECMO) can be a lifesaver. However, anticoagulation therapy is mandatory because the nonendothelial extracorporeal surface increases the risk of thromboembolic problems. Heparin is still… read more here.
Keywords: higher argatroban; membrane oxygenator; longevity higher; oxygenator longevity ... See more keywords